About
Artis BioSolutions develops and manufactures synthetic DNA and provides integrated services including process development, analytical development, and GMP manufacturing to support the discovery, development, and production of advanced genetic medicines such as cell therapies, gene therapies, mRNA, and gene editing.
Explore Artis BioSolutions's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.